Gliclazide Sustained-release Tablets
Barcode 6937951941110
Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
Location: China
Gliclazide Sustained-release Tablets are used for controlling blood glucose levels in adults with type 2 diabetes when diet, exercise, and weight loss alone do not provide adequate control. The packaging indicates a dosage of 30mg per tablet. No explicit environmental, social, or governance claims are visible.
Impacts
- Cut Energy Use and Emissions
- Education and Community Outreach
- Green Factory and Clean Production
- Land Restoration and Soil Care
- Strengthened Corporate Governance